Current Status of the Management of Mendelian Susceptibility to Mycobacterial Disease in Mainland China

Wenjing Ying,Danru Liu,Xiaolong Dong,Wenjie Wang,Xiaoying Hui,Jia Hou,Haili Yao,Qinhua Zhou,Bijun Sun,Jinqiao Sun,Xiaochuan Wang

Current Status of the Management of Mendelian Susceptibility to Mycobacterial Disease in Mainland China

2019

Wenjing Ying
Danru Liu
Xiaolong Dong
Wenjie Wang
Xiaoying Hui
Jia Hou
Haili Yao
Qinhua Zhou
Bijun Sun
Jinqiao Sun
Xiaochuan Wang

Purpose Although many studies have investigated Mendelian susceptibility to mycobacterial disease (MSMD) worldwide, there is no report of the long-term clinical management and prognosis for MSMD in China.

Keywords:

Interleukin 12 receptor, beta 1 subunit
Disease
Immunodeficiency
Virology
Mainland China
Mendelian inheritance
Biology
mycobacterial disease
Immunology
Medical microbiology
Cohort study
Internal medicine
Transplantation
IL12RB1 DEFICIENCY

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations